Actions of FRC8653 on the macroscopic and unitary Ba2`currents were studied using the rabbit basilar artery. Application of (+)-FRC8653 (<1 ,uM) increased the amplitude of the inward current when depolarization pulses more negative than -10 mV were applied but inhibited it when depolarization was more positive than 0 mV (in each case from a holding potential of -80 mV). At a holding potential of -40 mV, (-)-FRC8653 (>0.1 nM) consistently inhibited the inward current. (-)-FRC8653 (>1 nM) inhibited the amplitude of the inward current evoked by a depolarizing pulse more positive than -10 mV (the holding potential being -80 mV). At the holding potential of -80 mV, but not at -40 mV, (+)-FRC8653 (1 ,uM) enhanced the current amplitude evoked by a depolarizing pulse more negative than -10 mV but inhibited the current evoked by a pulse more positive than 0 mV. (-+-)-FRC8653 shifted the voltage-dependent inhibition curves to the left, and the slope of the curve became steeper (test pulse of + 10 mV). Ca2' channel or L-type channel without effect on the low-threshold Ca2' channel, the T-type.3-57 Moreover, it has been reported that DHP derivatives inhibited other ion channels such as the voltage-dependent K' channels and Na+ channels in cardiac and smooth muscle cells, although the required concentration was 200-1,000 times higher.8'9 These results indicate that DHP derivatives have selective inhibitory actions on the high-threshold-type (L-type) Ca2' channel in
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In contrast, some DHP derivatives, namely, Bay K 8644 and 202-791, are reported to enhance the high-threshold Ca21 channels but not the lowthreshold one.11 '2 Because such augmentation of the Ca2+ current by DHP derivatives was reported using nifedipine as well as nitrendipine, this action may be a common property of DHP derivatives and may play a role in their apparent inhibitory actions.'3 Therefore, it seems that the potency of the inhibitory
In guinea pig basilar artery, Fujiwara and Kuriyama14 reported that nicardipine, a DHP derivative, inhibited the action potential and the high-K+-induced contraction but not the 5-hydroxytryptamine-induced contraction, and they postulated that nicardipine selectively inhibited Ca + permeation through the voltage-dependent Ca2' channel in the membrane. However, no patch-clamp investigation has been performed using basilar artery.
(± )-FRC8653 [2-methoxyethyl (E)-3 -phenyl-2-propen-1-yl( ± )-1,4 -dihydro-2,6 -dimethyl-4 -(3-nitrophenyl)pyridine-3,5-dicarboxylate] is a newly synthesized DHP derivative and produces vasodilation, especially in the basilar and coronary arteries. 15 The present experiments were performed to investigate in detail the actions of (+t)-FRC8653 and its enantiomers on smooth muscle cells of the rabbit basilar artery.
Materials and Methods
Male albino rabbits (1.7-2.0 kg) were anesthetized with sodium pentobarbital (40 mg/kg i.v.; Pitman-Moore Inc., Washington Cross, N.J.) and exsanguinated. The basilar artery was dissected along with brain and brain stem and isolated in physiological salt solution (PSS). Tunica adventitia and surrounding connective tissue were carefully removed, as far as possible, with fine scissors and forceps under a binocular microscope. Endothelium was also removed by gentle rubbing with a small cotton ball. The procedure for cell dispersion was similar to that described by Momose Figure 1 . FRC8653 (100 mM) was dissolved in 50% polyethylene glycol (PEG)-50% ethanol solution and diluted with ethanol to keep the final concentration of ethanol constant (0.1%). Although the maximum concentrations of PEG (0.05%) and ethanol (0.1%) used in the present experiments did not produce any effect on the membrane currents, the same concentrations of PEG (0.05%) and ethanol (0.1%) were added in the control solutions.
Results
Under control conditions, the Ba2`inward current amplitude remained the same for over 30 minutes; therefore, all experiments were performed within 30 minutes. Figure 2 shows the time course of inhibition of the Ba21 inward current evoked by a depolarizing pulse of + 10 mV from the holding potential of -80 mV. When depolarizing pulses were applied every 20 seconds, (±)-FRC8653 (100 nM) gradually inhibited the amplitude of the Ba21 inward current, and maximum inhibition was reached after 4 minutes ( Figure  2A , open circles). The Ba2+ inward current amplitude was not completely restored after removal of (+)-FRC8653 even after 30 minutes.
Effects of (±)-FRC8653 on Macroscopic Ca2+ (Ba2+) Currents in the Rabbit Basilar Artery
In 10 mM Ca2+ solution, application of a depolarizing pulse (more positive than -40 mV) evoked an inward current, and the maximum amplitude was evoked by depolarizing pulses of +10 to +20 mV ( Figure 3Aa , open circles). Application of (+)-FRC8653 (100 nM) inhibited the inward current amplitude evoked by depolarizing pulses more positive than 0 mV, but slightly enhanced the current amplitude evoked by depolarizing pulses more negative than -10 mV (Figure 3Aa, closed circles) . Under the influence of the drug, the maximum inward current amplitude was obtained by depolarizing pulses of 0 to + 10 mV. (± )-FRC8653 consistently inhibited the inward current amplitude measured at peak or at the end of the depolarizing pulse (100 msec in duration and more positive than 0 mV). However, (±)-FRC8653 more profoundly inhibited the current amplitude measured at the end of depolarizing pulse than it did that measured at the peak amplitude. As shown in the top tracing in Figure 3Ab , the augmentation induced by (±+)-FRC8653 is seen only in the early phase of the inward current evoked by a depolarizing pulse of -20 mV.
To enable further study of the actions of (±)-FRC8653, 10 mM Ba2+ solution was superfused in the bath instead of the 10 mM Ca2' solution, because the Ca2' current has been reported to be inactivated by an increase in concentration of intracellular Ca2', as well as by depolarization of the membrane.20-22 In the 10 mM Ba21 solution, the Ba2+ inward current amplitude was larger and the decay was slower than their equivalents in the Ca21 inward current experiments. However, the shape of the current-voltage relation in the absence of (±+)- increased the amplitude evoked by depolarization pulses more negative than -10 mV (holding potential, -80 mV; Figure 3Ba , closed circles). Enhancement of the inward current induced by (±)-FRC8653 (100 nM) was seen only during the early phase of the inward current ( Figure 3Bb , top tracing), and decay of the inward current evoked by any given depolarizing pulse was steeper than that observed in the control (Figure 3Bb ). Figure 4 shows the relation between the concentration of (±)-FRC8653 and the relative amplitude of the Ba21 inward current evoked by depolarizing pulses of +10 mV or -20 mV from holding potentials of either -80 mV or -40 mV. Figure 4A shows that at the holding potential of -80 mV, (±)-FRC8653 (>0.1 nM) inhibited the Ba2+ inward current evoked by a depolarizing pulse of + 10 mV, but that even application of 20 ,M (±)-FRC8653 did not completely inhibit the Ba2+ inward current. The 50% inhibitory concentration (IC50) of (±)-FRC8653 on the Ba2+ inward current evoked by the depolarizing pulse of + 10 mV was 1 ,uM at the holding potential of -80 mV. On the other hand, at the holding potential of -40 mV, (±)-FRC8653 potently inhibited the Ba2+ inward current; application of 1 ,uM (±)-FRC8653 completely inhibited the Ba21 inward current, and the ICO value was 1 nM. In contrast, an enhancement of the Ba2+ inward current amplitude occurred in a concentration-dependent manner (1 nM to 1 ,uM), when the effects of (±)-FRC8653 were explored using a depolarizing pulse of -20 mV from the holding potential of -80 mV ( Figure  4B) . A Figure 6 shows the relation between the relative amplitude of the Ba2+ inward current evoked by two different depolarizing pulses (+10 mV and -20 mV) and the concentration of (+)-or (-)-FRC8653. The inhibitory action of (-)-FRC8653 on the Ba2+ inward current was more potent than that of the (+) enantiomer [IC50 of (-)-FRC8653, 60 nM; IC50 of (+)-FRC8653, 1.5 ,uM; Figure 6A ]. When a depolarizing pulse of -20 mV from the holding potential of -80 mV was applied, (-)-FRC8653 (<10 uM) inhibited, but the (+) enantiomer (< 100 nM) augmented, the Ba2+ inward current amplitude in a concentration-dependent manner. A higher concentration of (+)-FRC8653 (10 uM) caused no increase above control in the Ba2+ current amplitude ( Figure 6B) . Figure 7A ). However, even with application of a conditioning pulse of +20 mV, about 15% of the Ba2+ inward current was not inactivated (noninactivating component13,23). When a Boltzmann's distribution was adopted for the present voltage-dependent inactivation curve, the curve did not fit with a single slope factor, as shown in Figure 7A conditioning pulses more negative than -60 mV but inhibited the current evoked by conditioning pulses more positive than -50 mV.
Effects of (±)-FRC8653 on the K' Outward Current in Smooth Muscle Cell Membranes of the Rabbit Basilar Artery
To investigate the effects of (±)-FRC8653 on the K' outward current, various concentrations of (+)-FRC8653 were applied to the cells in a PSS bath. As shown in Figure 8A , (±)-FRC8653 (3 and 10 gM)
inhibited the amplitude of the outward current evoked by any given depolarizing pulse (-30 to +40 mV; holding potential, -60 mV). The inhibition of the outward current was completely reversible after removal of the drug. Applications of (±)-FRC8653 (> 1 ,uM) inhibited the outward current in a concentration-dependent manner ( Figure 8B ). The IC50 value of (+)-FRC8653 for the K' outward current was about 3 ,uM; this value was three times higher than that for the Ba2`inward current measured at the holding potential of -80 mV, but 3,000 times higher than that measured at the holding potential of -40 mV (see Figure 4) .
Recording of the Single Ba2`Channel Current From
Smooth Muscle Cells of the Rabbit Basilar Artery Figure 9A shows the current- Figure 10 shows the effects of (+)-FRC8653 on the 12-pS channel current evoked by repetitively applied depolarizing pulses to -20 mV from the holding potential of -80 mV (20-second interval, 150 msec in duration). In the absence of (+)-FRC8653, 43 of 72 depolarization pulses evoked channel opening (nonblank tracings), but the other 29 pulses did not (blank tracings). Essentially, the same result was obtained in the presence of 100 nM (+)-FRC8653 (42 nonblank and 31 blank tracings from 73 depolarizing pulses). In Figure 10 , the lower tracings show summated currents of the 12-pS channel in the absence or presence of 100 nM (+)-FRC8653. There is no significant difference in the amplitude or the shape before or after application of (+)-FRC8653. Figure 11A shows the effects of (+)-FRC8653 (100 nM) on the 23 -pS channel current evoked by a depolarizing pulse of -20 mV. In this membrane patch, both 12-and 23-pS channels were simultaneously opened, and in 56 of 72 depolarizing pulses, the 23-pS channel opened. In the presence of 100 nM (+)-FRC8653, the number of depolarizing pulses needed to record 50 nonblank tracings was reduced to 58. As shown in the bottom tracings, the amplitude of the summated currents was increased by 100 nM The characteristics of (±)-FRC8653, a novel DHP derivative, as determined in the present experiments may be summarized as follows. 1) (±)-FRC8653 had a dual action, producing both excitatory and inhibitory effects, on the Ba inward current. The (+) enantiomer mainly had excitatory, and the (-) enantiomer inhibitory, actions. The excitatory action of the (+) enantiomer was easily reversed to an inhibitory action by elevation of the membrane potential (to -40 mV). Figure 4A at a holding potential of -80 mV) may reflect a contamination of the agonistic action of the drug, because such a step was not observed in the concentration-inhibition curve observed at the holding potential of -40 mV ( Figure 4A) . Similarly, the turning down of the augmentation curve of the Ba2c urrent (depolarizing pulse, -20 mV; holding potential, -80 mV) observed after application of (±)-FRC8653 and of the (+) enantiomer (>10 ,M) also may be due to contamination of antagonistic actions. Therefore, the overall actions of (±)-FRC8653 can be expressed as the sum of the agonistic and antagonistic actions of the (+) and (-) enantiomers.
The voltage-dependent inactivation curves showed that 15% of the inward current was not inactivated above +10 mV of conditioning depolarization and that (±)-FRC8653 (100 nM) inhibited this component, as reported in other smooth muscle cells. 13 
